Sign inJoin waitlistJoin the waitlist

Benjamin Teply

Associate Professor, UNMC Division of Medical Oncology · University of Nebraska Medical Center College of Medicine

Credentials: · · · · ·

History

University of Nebraska Medical Center College of Medicine
Present

Hospice and Palliative Medicine
Johns Hopkins University School of Medicine
2017–2018
Johns Hopkins University School of Medicine
2015–2017
Internal Medicine
University of Michigan
2011–2013
University of Nebraska Medical Center
2006–2010

Research

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Proceedings of the National Academy of Sciences of the United States of America · 2006 · 1,179 citations
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery
Biomaterials · 2007 · 810 citations
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 555 citations

Emmanuel Antonarakis
9 papers
OF
Omid Farokhzad
7 papers
Sandy Srinivas
7 papers
Ahmad Shabsigh
6 papers
Anthony D'Amico
6 papers
Daniel Spratt
6 papers
Heather Cheng
6 papers
JE
James Eastham
6 papers
Jonathan Tward
6 papers · 4 as a resident
Joseph Ippolito
6 papers
Joshua Lang
6 papers
Michael Kuettel
6 papers

Clinical trials

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2024–2034
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Site PI · Recruiting · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2020–2028
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2019–2027
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2018–2031